GeneDx Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . GeneDx Holdings Corp
WGS Stock   94.46  4.01  4.07%   
GeneDx Holdings financial statements provide useful quarterly and yearly information to potential GeneDx Holdings Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on GeneDx Holdings financial statements helps investors assess GeneDx Holdings' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting GeneDx Holdings' valuation are summarized below:
Gross Profit
194.5 M
Profit Margin
(0.17)
Market Capitalization
2.8 B
Enterprise Value Revenue
8.9621
Revenue
305.4 M
There are over one hundred nineteen available fundamental trends for GeneDx Holdings Corp, which can be analyzed over time and compared to other ratios. All traders should confirm GeneDx Holdings' regular fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 2.2 B in 2025. Enterprise Value is likely to gain to about 2.1 B in 2025

GeneDx Holdings Total Revenue

243.91 Million

Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 30.9 M or Interest Expense of 2.7 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0 or PTB Ratio of 8.85. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
  
Check out the analysis of GeneDx Holdings Correlation against competitors.

GeneDx Holdings Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Current Liabilities50.3 M43.5 M22 M
Slightly volatile
Total Current Liabilities86.7 M54.8 M57.6 M
Slightly volatile
Other Liabilities45.5 M24 M27.5 M
Slightly volatile
Accounts Payable7.6 M8 M19.9 M
Very volatile
Other Assets0.860.94.8 M
Pretty Stable
Net Receivables35.6 M37.6 M26.5 M
Slightly volatile
Common Stock Shares Outstanding28.2 M26.9 M10.4 M
Slightly volatile
Inventory14.3 M10.7 M16.6 M
Very volatile
Other Current Assets12.8 M8.5 M5.7 M
Slightly volatile
Deferred Long Term Liabilities1.6 M3.1 M1.1 M
Slightly volatile
Total Current Assets188.6 M198 M192.3 M
Slightly volatile
Property Plant Equipment67.5 M96.9 M50.7 M
Slightly volatile
Total Assets481.7 M419.4 M324.2 M
Slightly volatile
Short and Long Term Debt Total73.5 M64.3 M53.6 M
Slightly volatile
Property Plant And Equipment Net52.5 M58.5 M63.2 M
Very volatile
Current Deferred Revenue34.2 K36 K1.3 M
Slightly volatile
Cash130.8 M85.2 M126.9 M
Pretty Stable
Non Current Assets Total206.6 M221.4 M120.1 M
Slightly volatile
Long Term Debt31 M51.9 M22.6 M
Slightly volatile
Cash And Short Term Investments144.6 M141.2 M133.1 M
Slightly volatile
Liabilities And Stockholders Equity481.7 M419.4 M324.2 M
Slightly volatile
Non Current Liabilities Total155.5 M119.3 M388.1 M
Slightly volatile
Capital Lease Obligations53.5 M64.3 M33.7 M
Slightly volatile
Total Liabilities224.8 M174.1 M465.4 M
Slightly volatile
Property Plant And Equipment Gross112 M111 M97.1 M
Slightly volatile
Short and Long Term Debt424.9 K447.3 K1.9 M
Very volatile
Non Current Liabilities Other13.9 M25.3 M7.5 M
Slightly volatile
Net Working Capital130.9 M143.2 M122.2 M
Slightly volatile
Short Term Debt4.3 M3.3 M5.3 M
Very volatile
Common Stock1.7 K1.8 K20.7 K
Slightly volatile
Common Stock Total Equity30.4 K34.2 K37.3 K
Slightly volatile
Long Term Debt Total5 M5.6 M6.1 M
Slightly volatile
Capital Surpluse1.1 B1.2 B1.4 B
Slightly volatile
Intangible Assets138.1 M158.6 M181 M
Slightly volatile
Accumulated Other Comprehensive Income690.2 K830 K466.9 K
Slightly volatile

GeneDx Holdings Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income3.1 M2.9 M1.3 M
Slightly volatile
Depreciation And Amortization30.9 M38.8 M16.8 M
Slightly volatile
Interest Expense2.7 M3.5 M1.6 M
Slightly volatile
Selling General Administrative142 M101.1 M73.9 M
Slightly volatile
Selling And Marketing Expenses87.7 M67.4 M57.5 M
Slightly volatile
Total Revenue243.9 M305.4 M208.7 M
Slightly volatile
Other Operating Expenses493.2 M325.3 M326.4 M
Slightly volatile
Research Development53.7 M45.7 M48.2 M
Slightly volatile
Cost Of Revenue137.6 M111.1 M136.9 M
Slightly volatile
Total Operating Expenses304 M214.2 M186.3 M
Slightly volatile
Reconciled Depreciation28.4 M22 M15.1 M
Slightly volatile
Non Recurring168.1 M189.1 M206.2 M
Slightly volatile
Non Operating Income Net Other58.3 M65.5 M71.5 M
Slightly volatile

GeneDx Holdings Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow160.4 M100.7 M65.4 M
Slightly volatile
Other Cashflows From Financing Activities846.5 K891 K105.3 M
Slightly volatile
Depreciation28.8 M22 M15.2 M
Slightly volatile
Capital Expenditures5.2 M5.5 M14.9 M
Slightly volatile
Total Cash From Financing Activities42 M44.2 M160.8 M
Very volatile
End Period Cash Flow127.9 M86.2 M132.7 M
Pretty Stable
Change To Netincome78.9 M154 M43.8 M
Slightly volatile
Change To Liabilities19 M17.2 M16.1 M
Slightly volatile
Sale Purchase Of Stock160.5 M180.5 M196.8 M
Slightly volatile
Change Receivables4.4 M5 M5.4 M
Slightly volatile
Cash Flows Other Operating10.6 M11.9 M13 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.986.76668.3573
Slightly volatile
Days Sales Outstanding62.2644.965162.7116
Slightly volatile
Capex To Depreciation0.240.25011.7933
Slightly volatile
Inventory Turnover9.5410.42758.7099
Slightly volatile
Days Of Inventory On Hand40.0435.003646.3622
Slightly volatile
Payables Turnover7.2313.96197.3735
Slightly volatile
Sales General And Administrative To Revenue0.470.3310.3352
Slightly volatile
Research And Ddevelopement To Revenue0.140.14970.2266
Slightly volatile
Capex To Revenue0.01710.0180.0743
Slightly volatile
Cash Per Share4.995.2502478.1 K
Slightly volatile
Days Payables Outstanding24.8426.142651.5774
Slightly volatile
Income Quality0.530.5450.6343
Very volatile
Intangibles To Total Assets0.410.37820.3809
Pretty Stable
Current Ratio2.463.61142.5935
Slightly volatile
Receivables Turnover5.328.11745.8763
Slightly volatile
Capex Per Share0.190.204212.9 K
Pretty Stable
Revenue Per Share10.7911.358772.1 K
Pretty Stable
Interest Debt Per Share2.162.2767210 K
Slightly volatile
Debt To Assets0.130.15320.1694
Pretty Stable
Operating Cycle10279.9686109
Slightly volatile
Days Of Payables Outstanding24.8426.142651.5774
Slightly volatile
Ebt Per Ebit2.382.26721.121
Slightly volatile
Quick Ratio2.273.41722.3
Slightly volatile
Net Income Per E B T1.090.99351.023
Slightly volatile
Cash Ratio2.11.55451.6474
Pretty Stable
Cash Conversion Cycle35.4153.826154.8683
Slightly volatile
Days Of Inventory Outstanding40.0435.003646.3622
Slightly volatile
Days Of Sales Outstanding62.2644.965162.7116
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.391.19271.5853
Slightly volatile
Fixed Asset Turnover2.825.22083.0547
Slightly volatile
Debt Ratio0.130.15320.1694
Pretty Stable
Price Sales Ratio3.986.76668.3573
Slightly volatile
Asset Turnover0.440.72830.6435
Slightly volatile

GeneDx Holdings Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.2 B2.1 B1.8 B
Slightly volatile

GeneDx Fundamental Market Drivers

Cash And Short Term Investments141.2 M

GeneDx Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About GeneDx Holdings Financial Statements

GeneDx Holdings shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although GeneDx Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in GeneDx Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on GeneDx Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue36 K34.2 K
Total Revenue305.4 M243.9 M
Cost Of Revenue111.1 M137.6 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 0.33  0.47 
Research And Ddevelopement To Revenue 0.15  0.14 
Capex To Revenue 0.02  0.02 
Revenue Per Share 11.36  10.79 
Ebit Per Revenue(0.08)(0.08)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY